Choice of measures of vaccination and estimates of risk of pediatric pertussis

Vaccine

Volumn 33, Issue 32, 2015, Pages 3970-3975

  Goldstein, Neal D ^a   Newbern, E Claire ^b   Evans, Alison A ^a   Drezner, Kate ^b,c   Welles, Seth L ^a  

^a DREXEL UNIVERSITY   (United States)

^b PHILADELPHIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^c NATIONAL ASSOCIATION OF COUNTY AND CITY HEALTH OFFICIALS   (United States)

Author keywords

Bordatella pertussis; DTaP; Immunization; Pediatric; Whooping cough

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; PERTUSSIS VACCINE;

ARTICLE; CASE CONTROL STUDY; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DOSE RESPONSE; DRUG UPTAKE; FEMALE; GROUPS BY AGE; HEALTH STATUS; HUMAN; IMMUNITY; INFANT; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PERTUSSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RISK REDUCTION; UNITED STATES; VACCINATION; DRUG UTILIZATION; PENNSYLVANIA; RISK ASSESSMENT; WHOOPING COUGH;

CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION; FEMALE; HUMANS; INFANT; MALE; PERTUSSIS VACCINE; PHILADELPHIA; RISK ASSESSMENT; WHOOPING COUGH;

EID: 84937519961     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.06.033     Document Type: Article

References (39)

1. Bates A.S., Wolinsky F.D. Personal, financial, and structural barriers to immunization in socioeconomically disadvantaged urban children. Pediatrics 1998, 101(4 Pt 1):591-596.
2. Bobo J.K., Gale J.L., Thapa P.B., Wassilak S.G. Risk factors for delayed immunization in a random sample of 1163 children from Oregon and Washington. Pediatrics 1993, 91(2):308-314.
3. Centers for Disease Control and Prevention (CDC) National, state, and local area vaccination coverage among adolescents aged 13-17 years-United States, 2008. MMWR Morb Mortal Wkly Rep 2009, 58(Sep (36)):997-1001.
4. Sakou I.I., Tsitsika A.K., Papaevangelou V., Tzavela E.C., Greydanus D.E., Tsolia M.N. Vaccination coverage among adolescents and risk factors associated with incomplete immunization. Eur J Pediatr 2011, 170(11):1419-1426.
5. Koepke C.P., Vogel C.A., Kohrt A.E. Provider characteristics and behaviors as predictors of immunization coverage. Am J Prev Med 2001, 21(Nov (4)):250-255.
6. Vandermeulen C., Roelants M., Theeten H., Depoorter A.M., Van Damme P., Hoppenbrouwers K. Vaccination coverage in 14-year-old adolescents: documentation, timeliness, and sociodemographic determinants. Pediatrics 2008, 121(3):e428-e434.
7. Williams I.T., Milton J.D., Farrell J.B., Graham N.M. Interaction of socioeconomic status and provider practices as predictors of immunization coverage in Virginia children. Pediatrics 1995, 96(Sep (3 Pt 1)):439-446.
8. Dayan G.H., Shaw K.M., Baughman A.L., Orellana L.C., Forlenza R., Ellis A., et al. Assessment of delay in age-appropriate vaccination using survival analysis. Am J Epidemiol 2006, 163(Mar (6)):561-570. (Epub 2006 Jan 18).
9. Centers for Disease Control and Prevention (CDC) National Immunization Survey (NIS)-children (19-35 months) 2013, Available at: 〈http://www.cdc.gov/vaccines/imz-managers/coverage/nis/child/index.html〉 (accessed August 15, 2014).
10. Luman E.T., Barker L.E., Shaw K.M., McCauley M.M., Buehler J.W., Pickering L.K. Timeliness of childhood vaccinations in the United States: days undervaccinated and number of vaccines delayed. JAMA 2005, 293(Mar (10)):1204-1211.
11. Glanz J.M., Narwaney K.J., Newcomer S.R., Daley M.F., Hambidge S.J., Rowhani-Rahbar A., et al. Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age. JAMA Pediatr 2013, 167(11):1060-1064.
12. Barlow R.S., Reynolds L.E., Cieslak P.R., Sullivan A.D. Vaccinated children and adolescents with pertussis infections experience reduced illness severity and duration, Oregon, 2010-2012. Clin Infect Dis 2014, 58(Jun (11)):1523-1529.
13. Dombkowski K.J., Lantz P.M., Freed G.L. Risk factors for delay in age-appropriate vaccination. Public Health Rep 2004, 119(Mar-Apr (2)):144-155.
14. Philadelphia Department of Public Health PDPH health information portal>disease reporting 2013, Available at: 〈https://hip.phila.gov/xv/DiseaseReporting/tabid/120/Default.aspx〉 (accessed November 8, 2013).
15. Akinsanya-Beysolow I., Jenkins R., Meissner H.C., Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recommended immunization schedule for persons aged 0 through 18 years-United States, 2013. MMWR Surveill Summ 2013, 62(Feb (Suppl. 1)):2-8. ACIP Childhood/Adolescent Immunization Work Group.
16. Modern epidemiology 2008, Lippincott Williams & Wilkins, Philadelphia, PA. K.J. Rothman, S. Greenland, T.L. Lash (Eds.).
17. Orenstein W.A., Bernier R.H., Dondero T.J., Hinman A.R., Marks J.S., Bart K.J., et al. Field evaluation of vaccine efficacy. Bull World Health Organ 1985, 63(6):1055-1068.
18. Neitzel R.L., Daniell W.E., Sheppard L., Davies H.W., Seixas N.S. Improving exposure estimates by combining exposure information. Ann Occup Hyg 2011, 55(Jun (5)):537-547.
19. Khetsuriani N., Bisgard K., Prevots D.R., Brennan M., Wharton M., Pandya S., et al. Pertussis outbreak in an elementary school with high vaccination coverage. Pediatr Infect Dis J 2001, 20(12):1108-1112.
20. Bisgard K.M., Rhodes P., Connelly B.L., Bi D., Hahn C., Patrick S., et al. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Pediatrics 2005, 116(Aug (2)):e285-e294.
21. Briand V., Bonmarin I., Lévy-Bruhl D. Study of the risk factors for severe childhood pertussis based on hospital surveillance data. Vaccine 2007, 25(Oct (41)):7224-7232.
22. Farizo K.M., Cochi S.L., Zell E.R., Brink E.W., Wassilak S.G., Patriarca P.A. Epidemiological features of pertussis in the United States, 1980-1989. Clin Infect Dis 1992, 14(3):708-719.
23. Halperin S.A., Wang E.E., Law B., Mills E., Morris R., Déry P., et al. Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program-Active (IMPACT). Clin Infect Dis 1999, 28(6):1238-1243.
24. Khan F.N., Lin M., Hinkle C.J., Franklin P., Luther R., Woodruff F., et al. Case-control study of vaccination history in relation to pertussis risk during an outbreak among school students. Pediatr Infect Dis J 2006, 25(12):1132-1136.
25. Grant C.C., Roberts M., Scragg R., Stewart J., Lennon D., Kivell D., et al. Delayed immunisation and risk of pertussis in infants: unmatched case-control study. BMJ 2003, 326(Apr (7394)):852-853.
26. Gustafsson L., Hallander H.O., Olin P., Reizenstein E., Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 1996, 334(Feb (6)):349-355.
27. Greco D., Salmaso S., Mastrantonio P., Giuliano M., Tozzi A.E., Anemona A., et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N Engl J Med 1996, 334(Feb (6)):341-348.
28. Adams D.A., Jajosky R.A., Ajani U., Kriseman J., Sharp P., Onwen D.H., et al. Summary of notifiable diseases-United States, 2012. MMWR Morb Mortal Wkly Rep 2014, 61(Sep (53)):1-121.
29. Centers for Disease Control and Prevention (CDC) Pertussis-United States, 2001-2003. MMWR Morb Mortal Wkly Rep 2005, 54(Dec (50)):1283-1286.
30. Gerber J.S., Prasad P.A., Localio A.R., Fiks A.G., Grundmeier R.W., Bell L.M., et al. Racial differences in antibiotic prescribing by primary care pediatricians. Pediatrics 2013, 131(4):677-684.
31. Brenner R.A., Simons-Morton B.G., Bhaskar B., Das A., Clemens J.D. Prevalence and predictors of immunization among inner-city infants: a birth cohort study. Pediatrics 2001, 108(Sep (3)):661-70. NIH-D.C. Initiative Immunization Working Group.
32. Reading R., Surridge H., Adamson R. Infant immunization and family size. J Public Health (Oxf) 2004, 26(Dec (4)):369-371.
33. Trauth J.M., Zimmerman R.K., Musa D., Mainzer H., Nutini J.F. Do beliefs of inner-city parents about disease and vaccine risks affect immunization?. J Natl Med Assoc 2002, 94(9):820-832.
34. Tartof S.Y., Lewis M., Kenyon C., White K., Osborn A., Liko J., et al. Waning immunity to pertussis following 5 doses of DTaP. Pediatrics 2013, 131(4):e1047-e1052.
35. Domínguez A., Godoy P., Toledo D., Soldevila N., Garcí-Cenoz M., Farrús G., et al. Importance of enhanced surveillance for prevention of pertussis in children. Pediatr Infect Dis J 2015, 34(Jul (7)):729-733. Working Group for the Study of Pertussis in Catalonia and Navarre (Spain).
36. Fernández-Cano M.I., Armadans Gil L., Martínez Gómez X., Campins Martí M. Incidence of whooping cough in Spain (1997-2010): an underreported disease. Eur J Pediatr 2014, 173(Jun (6)):721-726.
37. Syed M.A., Bana N.F. Pertussis: a reemerging and an underreported infectious disease. Saudi Med J 2014, 35(10):1181-1187.
38. Guiso N., Wirsing von König C.H., Forsyth K., Tan T., Plotkin S.A. The global pertussis initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis Paris, France, 11-12 January 2010. Vaccine 2011, 29(Feb (6)):1115-1121.
39. Khare M., Piccinino L., Barker L.E., Linkins R.W. Assessment of immunization registry databases as supplemental sources of data to improve ascertainment of vaccination coverage estimates in the national immunization survey. Arch Pediatr Adolesc Med 2006, 160(8):838-842.